El gran benefici es reflecteix en el pacient cr\u00f2nic perqu\u00e8 aquest servei permet fer seguiment i registre, \u201cque ha d’estar en mans del metge, del farmac\u00e8utic i del pacient\u201d, assenyalen<\/li>\n<\/ul>\n\nMadrid, 24 de mar\u00e7. Millorar la col\u00b7laboraci\u00f3 i comunicaci\u00f3 entre professionals sanitaris mitjan\u00e7ant el consens de protocols i apoderar al pacient en l’autocura \u00e9s l’objectiu del projecte Indica+Pro (Servei d’Indicaci\u00f3 Farmac\u00e8utica per a S\u00edmptomes Menors en l’\u00c0mbit de la Farm\u00e0cia Comunit\u00e0ria). \u201c\u00c9s important parlar el mateix idioma i estar d’acord pel benefici del pacient. La seguretat ha d’estar damunt la taula en tot moment. Hem de treballar perqu\u00e8 el sistema sigui m\u00e9s sostenible\u201d, va dir Jes\u00fas V\u00e1zquez Castro, director general d’Asistencia Sanitaria y Aseguramiento de la Comunidad de Madrid, durant la taula de debat celebrada en el marc d\u2019Infarma Madrid 2022, moderada per Ana Mar\u00eda Molinero, vicepresidenta i responsable de l’\u00e0rea cient\u00edfica de la Sociedad Espa\u00f1ola de Farmacia Familiar y Comunitaria (SEFAC).<\/p>\n
Per part seva, Jes\u00fas C. G\u00f3mez Mart\u00ednez, farmac\u00e8utic comunitari i investigador del projecte Indica+Pro, va destacar que \u201cun dels punts forts sobre els quals es reflecteixen beneficis \u00e9s en el pacient cr\u00f2nic. Hem pogut detectar tumors, per exemple, perqu\u00e8 hem fet seguiment i registre. I aix\u00f2 ha d’estar en mans del metge, del farmac\u00e8utic i del pacient. Ha d’estar en una hist\u00f2ria comuna perqu\u00e8 puguem passar la informaci\u00f3 perqu\u00e8 aix\u00f2 agilitzaria passos i dona seguretat\u201d.<\/p>\n
Formaci\u00f3, informaci\u00f3 i visi\u00f3 del pacient<\/p>\n
Mar\u00eda Fern\u00e1ndez, presidenta de Sociedad Espa\u00f1ola de Medicina Familiar y Comunitaria (SemFYC), va posar l’accent en la necessitat que \u201cla informaci\u00f3 sigui cr\u00edtica des de la farm\u00e0cia, ha de ser la mateixa que s’ofereixi en el centre de salut i, per a aix\u00f2, estan els protocols. La informaci\u00f3 que es doni al pacient ha de ser consensuada i comprensible per al pacient segons l’entorn en el qual viu, ja que no \u00e9s el mateix la farm\u00e0cia rural que una del centre de ciutat, per exemple\u201d. Aix\u00ed mateix, va posar l’accent en la formaci\u00f3: \u201cNecessitem estar formats i, per aix\u00f2, establim convenis per a poder fer formaci\u00f3 als metges d’Atenci\u00f3 Prim\u00e0ria\u201d. I va deixar clar, una vegada m\u00e9s, que \u201cla farm\u00e0cia no ha de substituir al centre de salut, no \u00e9s servei de substituci\u00f3, sin\u00f3 complementari\u201d.<\/p>\n
Una cosa sobre la qual, com a pacient, tamb\u00e9 va destacar Manuel Arellano, vicepresident primer de l\u2019Asociaci\u00f3n para la Lucha Contra las Enfermedades del Ri\u00f1\u00f3n (ALCER). \u201cFalta per millorar tot all\u00f2 relacionat amb la intervenci\u00f3 multidisciplin\u00e0ria. \u00c9s un gran pas que hem de donar. Necessitem que l’atenci\u00f3 al pacient sigui sobre la base de la formaci\u00f3, avaluaci\u00f3 i continu\u00eftat en el seguiment de la malaltia. Els pacients cr\u00f2nics hem de saber les conseq\u00fc\u00e8ncies de no prendre la medicaci\u00f3\u201d, i va afegir que \u201ctenir un farmac\u00e8utic a prop \u00e9s un privilegi, per\u00f2 ha d’ajudar-nos a comprendre els perills de la medicaci\u00f3 que estem prenent. No tenim molta informaci\u00f3 sobre aquest tema\u201d.<\/p>\n
\u00c1ngela Gonz\u00e1lez Hern\u00e1ndez, farmac\u00e8utica comunit\u00e0ria i responsable del projecte Indica+Pro Madrid va anticipar que els resultats finals de l’estudi es presentaran durant el X Congr\u00e9s Nacional de Farmac\u00e8utics Comunitaris, que SEFAC celebrar\u00e0 del 5 al 7 de maig a Madrid, per\u00f2 va avan\u00e7ar que l’experi\u00e8ncia reflecteix que \u00e9s fonamental el seguiment de pacients. \u201cA la farm\u00e0cia moltes vegades dispensem i despr\u00e9s no sabem l’esdevenir. No obstant aix\u00f2, amb el servei Indica+Pro en un alt percentatge de pacients s\u00ed s’ha realitzat seguiment\u201d.<\/p>\n
\u00a0Els experts exposen els avantatges del Servei d’Indicaci\u00f3 Farmac\u00e8utica, Indica+Pro, en oferir seguretat en la medicaci\u00f3 i l’autocura, a m\u00e9s d’unificar la pr\u00e0ctica di\u00e0ria mitjan\u00e7ant protocols i permetre avaluar l’estalvi sanitari
\n\tEl gran benefici es reflecteix en el pacient cr\u00f2nic perqu\u00e8 aquest servei permet fer seguiment i registre, \u201cque ha d’estar en mans del metge, del farmac\u00e8utic i del pacient\u201d, assenyalen<\/p>\n
Madrid, 24 de mar\u00e7. Millorar la col\u00b7laboraci\u00f3 i comunicaci\u00f3 entre professionals sanitaris mitjan\u00e7ant el consens de protocols i apoderar al pacient en l’autocura \u00e9s l’objectiu del projecte Indica+Pro (Servei d’Indicaci\u00f3 Farmac\u00e8utica per a S\u00edmptomes Menors en l’\u00c0mbit de la Farm\u00e0cia Comunit\u00e0ria). \u201c\u00c9s important parlar el mateix idioma i estar d’acord pel benefici del pacient. La seguretat ha d’estar damunt la taula en tot moment. Hem de treballar perqu\u00e8 el sistema sigui m\u00e9s sostenible\u201d, va dir Jes\u00fas V\u00e1zquez Castro, director general d’Asistencia Sanitaria y Aseguramiento de la Comunidad de Madrid, durant la taula de debat celebrada en el marc d\u2019Infarma Madrid 2022, moderada per Ana Mar\u00eda Molinero, vicepresidenta i responsable de l’\u00e0rea cient\u00edfica de la Sociedad Espa\u00f1ola de Farmacia Familiar y Comunitaria (SEFAC).<\/p>\n
Per part seva, Jes\u00fas C. G\u00f3mez Mart\u00ednez, farmac\u00e8utic comunitari i investigador del projecte Indica+Pro, va destacar que \u201cun dels punts forts sobre els quals es reflecteixen beneficis \u00e9s en el pacient cr\u00f2nic. Hem pogut detectar tumors, per exemple, perqu\u00e8 hem fet seguiment i registre. I aix\u00f2 ha d’estar en mans del metge, del farmac\u00e8utic i del pacient. Ha d’estar en una hist\u00f2ria comuna perqu\u00e8 puguem passar la informaci\u00f3 perqu\u00e8 aix\u00f2 agilitzaria passos i dona seguretat\u201d.<\/p>\n
Formaci\u00f3, informaci\u00f3 i visi\u00f3 del pacient<\/p>\n
Mar\u00eda Fern\u00e1ndez, presidenta de Sociedad Espa\u00f1ola de Medicina Familiar y Comunitaria (SemFYC), va posar l’accent en la necessitat que \u201cla informaci\u00f3 sigui cr\u00edtica des de la farm\u00e0cia, ha de ser la mateixa que s’ofereixi en el centre de salut i, per a aix\u00f2, estan els protocols. La informaci\u00f3 que es doni al pacient ha de ser consensuada i comprensible per al pacient segons l’entorn en el qual viu, ja que no \u00e9s el mateix la farm\u00e0cia rural que una del centre de ciutat, per exemple\u201d. Aix\u00ed mateix, va posar l’accent en la formaci\u00f3: \u201cNecessitem estar formats i, per aix\u00f2, establim convenis per a poder fer formaci\u00f3 als metges d’Atenci\u00f3 Prim\u00e0ria\u201d. I va deixar clar, una vegada m\u00e9s, que \u201cla farm\u00e0cia no ha de substituir al centre de salut, no \u00e9s servei de substituci\u00f3, sin\u00f3 complementari\u201d.<\/p>\n
Una cosa sobre la qual, com a pacient, tamb\u00e9 va destacar Manuel Arellano, vicepresident primer de l\u2019Asociaci\u00f3n para la Lucha Contra las Enfermedades del Ri\u00f1\u00f3n (ALCER). \u201cFalta per millorar tot all\u00f2 relacionat amb la intervenci\u00f3 multidisciplin\u00e0ria. \u00c9s un gran pas que hem de donar. Necessitem que l’atenci\u00f3 al pacient sigui sobre la base de la formaci\u00f3, avaluaci\u00f3 i continu\u00eftat en el seguiment de la malaltia. Els pacients cr\u00f2nics hem de saber les conseq\u00fc\u00e8ncies de no prendre la medicaci\u00f3\u201d, i va afegir que \u201ctenir un farmac\u00e8utic a prop \u00e9s un privilegi, per\u00f2 ha d’ajudar-nos a comprendre els perills de la medicaci\u00f3 que estem prenent. No tenim molta informaci\u00f3 sobre aquest tema\u201d.<\/p>\n
\u00c1ngela Gonz\u00e1lez Hern\u00e1ndez, farmac\u00e8utica comunit\u00e0ria i responsable del projecte Indica+Pro Madrid va anticipar que els resultats finals de l’estudi es presentaran durant el X Congr\u00e9s Nacional de Farmac\u00e8utics Comunitaris, que SEFAC celebrar\u00e0 del 5 al 7 de maig a Madrid, per\u00f2 va avan\u00e7ar que l’experi\u00e8ncia reflecteix que \u00e9s fonamental el seguiment de pacients. \u201cA la farm\u00e0cia moltes vegades dispensem i despr\u00e9s no sabem l’esdevenir. No obstant aix\u00f2, amb el servei Indica+Pro en un alt percentatge de pacients s\u00ed s’ha realitzat seguiment\u201d.\u00a0\u00a0COFB.ORG<\/p>\n","protected":false},"excerpt":{"rendered":"
\u00a0 Els experts exposen els avantatges del Servei d’Indicaci\u00f3 Farmac\u00e8utica, Indica+Pro, en oferir seguretat en la medicaci\u00f3 i l’autocura, a m\u00e9s d’unificar la pr\u00e0ctica di\u00e0ria mitjan\u00e7ant protocols i permetre avaluar l’estalvi sanitari El gran benefici es reflecteix en el pacient cr\u00f2nic perqu\u00e8 aquest servei permet fer seguiment i registre, \u201cque […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1060,1066],"tags":[],"class_list":["post-76999","post","type-post","status-publish","format-standard","hentry","category-notes-premsa","category-sense-categoria-ca"],"yoast_head":"\n
Consens de protocols i apoderament del pacient en l'autocura, a debat a Infarma Madrid 2022 - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2022\/03\/24\/consens-de-protocols-i-apoderament-del-pacient-en-lautocura-a-debat-a-infarma-madrid-2022\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Consens de protocols i apoderament del pacient en l'autocura, a debat a Infarma Madrid 2022 - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"\u00a0 Els experts exposen els avantatges del Servei d’Indicaci\u00f3 Farmac\u00e8utica, Indica+Pro, en oferir seguretat en la medicaci\u00f3 i l’autocura, a m\u00e9s d’unificar la pr\u00e0ctica di\u00e0ria mitjan\u00e7ant protocols i permetre avaluar l’estalvi sanitari El gran benefici es reflecteix en el pacient cr\u00f2nic perqu\u00e8 aquest servei permet fer seguiment i registre, \u201cque […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2022\/03\/24\/consens-de-protocols-i-apoderament-del-pacient-en-lautocura-a-debat-a-infarma-madrid-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-03-24T18:00:00+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/03\/24\/consens-de-protocols-i-apoderament-del-pacient-en-lautocura-a-debat-a-infarma-madrid-2022\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/03\/24\/consens-de-protocols-i-apoderament-del-pacient-en-lautocura-a-debat-a-infarma-madrid-2022\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Consens de protocols i apoderament del pacient en l’autocura, a debat a Infarma Madrid 2022\",\"datePublished\":\"2022-03-24T18:00:00+00:00\",\"dateModified\":\"2022-03-24T18:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/03\/24\/consens-de-protocols-i-apoderament-del-pacient-en-lautocura-a-debat-a-infarma-madrid-2022\/\"},\"wordCount\":1359,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"articleSection\":[\"Notes de premsa\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/03\/24\/consens-de-protocols-i-apoderament-del-pacient-en-lautocura-a-debat-a-infarma-madrid-2022\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2022\/03\/24\/consens-de-protocols-i-apoderament-del-pacient-en-lautocura-a-debat-a-infarma-madrid-2022\/\",\"name\":\"Consens de protocols i apoderament del pacient en l'autocura, a debat a Infarma Madrid 2022 - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"datePublished\":\"2022-03-24T18:00:00+00:00\",\"dateModified\":\"2022-03-24T18:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/03\/24\/consens-de-protocols-i-apoderament-del-pacient-en-lautocura-a-debat-a-infarma-madrid-2022\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2022\/03\/24\/consens-de-protocols-i-apoderament-del-pacient-en-lautocura-a-debat-a-infarma-madrid-2022\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/03\/24\/consens-de-protocols-i-apoderament-del-pacient-en-lautocura-a-debat-a-infarma-madrid-2022\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Consens de protocols i apoderament del pacient en l’autocura, a debat a Infarma Madrid 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Consens de protocols i apoderament del pacient en l'autocura, a debat a Infarma Madrid 2022 - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2022\/03\/24\/consens-de-protocols-i-apoderament-del-pacient-en-lautocura-a-debat-a-infarma-madrid-2022\/","og_locale":"ca_ES","og_type":"article","og_title":"Consens de protocols i apoderament del pacient en l'autocura, a debat a Infarma Madrid 2022 - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"\u00a0 Els experts exposen els avantatges del Servei d’Indicaci\u00f3 Farmac\u00e8utica, Indica+Pro, en oferir seguretat en la medicaci\u00f3 i l’autocura, a m\u00e9s d’unificar la pr\u00e0ctica di\u00e0ria mitjan\u00e7ant protocols i permetre avaluar l’estalvi sanitari El gran benefici es reflecteix en el pacient cr\u00f2nic perqu\u00e8 aquest servei permet fer seguiment i registre, \u201cque […]","og_url":"https:\/\/novaorg.cofb.net\/2022\/03\/24\/consens-de-protocols-i-apoderament-del-pacient-en-lautocura-a-debat-a-infarma-madrid-2022\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2022-03-24T18:00:00+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"6 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2022\/03\/24\/consens-de-protocols-i-apoderament-del-pacient-en-lautocura-a-debat-a-infarma-madrid-2022\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2022\/03\/24\/consens-de-protocols-i-apoderament-del-pacient-en-lautocura-a-debat-a-infarma-madrid-2022\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Consens de protocols i apoderament del pacient en l’autocura, a debat a Infarma Madrid 2022","datePublished":"2022-03-24T18:00:00+00:00","dateModified":"2022-03-24T18:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2022\/03\/24\/consens-de-protocols-i-apoderament-del-pacient-en-lautocura-a-debat-a-infarma-madrid-2022\/"},"wordCount":1359,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"articleSection":["Notes de premsa"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2022\/03\/24\/consens-de-protocols-i-apoderament-del-pacient-en-lautocura-a-debat-a-infarma-madrid-2022\/","url":"https:\/\/novaorg.cofb.net\/2022\/03\/24\/consens-de-protocols-i-apoderament-del-pacient-en-lautocura-a-debat-a-infarma-madrid-2022\/","name":"Consens de protocols i apoderament del pacient en l'autocura, a debat a Infarma Madrid 2022 - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"datePublished":"2022-03-24T18:00:00+00:00","dateModified":"2022-03-24T18:00:00+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2022\/03\/24\/consens-de-protocols-i-apoderament-del-pacient-en-lautocura-a-debat-a-infarma-madrid-2022\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2022\/03\/24\/consens-de-protocols-i-apoderament-del-pacient-en-lautocura-a-debat-a-infarma-madrid-2022\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2022\/03\/24\/consens-de-protocols-i-apoderament-del-pacient-en-lautocura-a-debat-a-infarma-madrid-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Consens de protocols i apoderament del pacient en l’autocura, a debat a Infarma Madrid 2022"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"\u00a0 Els experts exposen els avantatges del Servei d’Indicaci\u00f3 Farmac\u00e8utica, Indica+Pro, en oferir seguretat en la medicaci\u00f3 i l’autocura, a m\u00e9s d’unificar la pr\u00e0ctica di\u00e0ria mitjan\u00e7ant protocols i permetre avaluar l’estalvi sanitari El gran benefici es reflecteix en el pacient cr\u00f2nic perqu\u00e8 aquest servei permet fer seguiment i registre, \u201cque […]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/76999","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=76999"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/76999\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=76999"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=76999"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=76999"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}